Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Community health workers take on high blood pressure and diabetes in the andes

NCT ID NCT05524987

Disease control Sponsor: Universidad Peruana Cayetano Heredia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether monthly home visits from trained health agents can help people in poor, high-altitude communities in Peru better control their high blood pressure and diabetes. Over 1,000 participants will either receive these visits for a year or get usual care. The goal is to see if the home visits lead to lower blood pressure and better blood sugar levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
health agent home visits
What this could lead to
If successful, this could provide a low-cost, community-based model to improve blood pressure and diabetes control in remote, underserved populations.
What could go wrong
This is a single study in one region of Peru, so results may not apply elsewhere. The intervention is behavioral, so adherence and long-term effects are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,068 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosis of HTN, defined as one or more of the following: 1. Physician-prescribed use of antihypertensive medications, and SBP≥130 mmHg and/or DBP≥80 mmHg 2. Physician diagnosed hypertension defined as a hypertensive blood pressure measurement (SBP≥140 mmHg and/or DBP≥90 mmHg) documented or measured on two or more separate occasions. 2. Willing and available to receive health agent home visits monthly for the next year. 3. Receiving healthcare through MINSA or EsSalud healthcare systems Exclusion Criteria: 1. Less than 18 years old;. 2. Has a SBP less than 140 mmHg and DBP less than 90 mmHg and is not currently taking medication; 3. Has a SBP less than 130 mmHg and DBP less than 80 mmHg if currently taking hypertension medication; 4. Unwilling, unable, or or not cognitively capable of providing informed consent; 5. Pregnant or plan to become pregnant in the next 18 months; 6. Plan to move out of the study area in the next 18 months; 7. Are not ambulatory, particularly if bedridden; 8. Currently receives home medical visits; 9. Life expectancy less than 6 months. 10. Lives more than approximately 1 hour from Puno city center; 11. Plan to travel for more than 3 months in the next year; 12. Another ANDES participant already lives in their home; 13. Patients on dialysis or expecting to start dialysis within the next 12 months; 14. Patients with liver failure (meeting Child-Pugh B or C criteria)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypertensive disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes Hypertension

Contacts and locations

Locations

  • PRISMA

    Puno, Puno, Peru

More trials for these conditions

Other studies related to the condition(s) this trial covers.